id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-323910-lms3xw4k	Putman, Michael	Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis	2020-08-02		.txt	text/plain	4592	293	46	In this systematic review and meta-analysis, we identified and summarized published and pre-print original scientific articles that described the use of antirheumatic disease therapies for the treatment of COVID-19. The final eligibility criteria were (1) Included 5 or more people infected with SARS-CoV-2; (2) antirheumatic disease therapy (Supplemental Appendix); (3) published after January 1st, 2019; (4) original research; (5) had one of the following outcomes: Death, ventilator-free days, escalation of care (ICU transfer), length of hospital stay, symptom resolution, viral clearance. For reporting purposes and due to the methodological diversity of the studies, we prioritized results for summary and synthesis based on study design (RCT > cohort studies > case series), risk of bias assessment (low risk > some concerns > high risk) and relevance of the outcome (e.g. mortality > viral clearance). All rights reserved DISCUSSION In this systematic review and meta-analysis of antirheumatic disease therapies for the treatment of COVID-19, the use of hydroxychloroquine was not associated with mortality.	./cache/cord-323910-lms3xw4k.txt	./txt/cord-323910-lms3xw4k.txt